OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Microbiology Reviews is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Antimicrobial Resistance in ESKAPE Pathogens	920
Coronavirus Disease 2019–COVID-19	661
New β-Lactam–β-Lactamase Inhibitor Combinations	249
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection	200
Remdesivir against COVID-19 and Other Viral Diseases	169
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders	160
Antifungal Susceptibility Testing: Current Approaches	142
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection	136
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis	127
Performance and Application of 16S rRNA Gene Cycle Sequencing for Routine Identification of Bacteria in the Clinical Microbiology Laboratory	124
Host-Directed Antiviral Therapy	107
Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries	105
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria	98
Pathogenesis of Gram-Negative Bacteremia	98
Yersinia pestis: the Natural History of Plague	93
Microsporidiosis in Humans	91
Convalescent Plasma Therapy for COVID-19: State of the Art	86
The Changing Face of the Family Enterobacteriaceae (Order: “ Enterobacterales ”): New Members, Taxonomic Issues, Geographic Expansion, and	86
Evolutionary Pathways and Trajectories in Antibiotic Resistance	78
Advances in the Microbiology of Stenotrophomonas maltophilia	78
Viral Respiratory Pathogens and Lung Injury	77
Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis	72
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies	71
Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products	69
Pathogenesis of Respiratory Viral and Fungal Coinfections	66

Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis	65
Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters	64
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes	64
Intrathecal Antibacterial and Antifungal Therapies	61
Laboratory Diagnosis of Lyme Borreliosis	61
SARS-CoV-2 Antiviral Therapy	59
Giardia duodenalis: Biology and Pathogenesis	56
Taenia solium Cysticercosis and Its Impact in Neurological Disease	55
Molecular Epidemiology of Human Cryptosporidiosis in Low- and Middle-Income Countries	55
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence	50
Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation	46
Human Listeriosis	45
Environmental, Microbiological, and Immunological Features of Bacterial Biofilms Associated with Implanted Medical Devices	45
Staphylococcus lugdunensis: a Skin Commensal with Invasive Pathogenic Potential	45
Interplay between Candida albicans and Lactic Acid Bacteria in the Gastrointestinal Tract: Impact on Colonization Resistance, Microbial Carriage, Opportunistic Infection, and Host Immunity	41
SARS-CoV-2 and Health Care Worker Protection in Low-Risk Settings: a Review of Modes of Transmission and a Novel Airborne Model Involving Inhalable Particles	41